EUCTR2009-016591-68-DKActive, not recruitingNot Applicable
Placebo-controlled trial investigating the effect of Vitamin K3-lotion for the treatment of cetuximab induced folliculitis - Vitamin K3
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Odense University Hospital
- Enrollment
- 36
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •- Planned or ongoing treatment with cetuximab.
- •- Age at least 18 years old.
- •- Informed consent according to local and national legislation
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •- No known disease which can influence treatment, evaluation and the outcome of the current disease and treatment - including chronic diseases of the skin
- •- No known hypersensitivity to menadion.
- •- No concomitant treatment with Vitamin K or Vitamin K-antagonists
- •- No present psychological, familily, sociological or geographical conditions, which potentially could prevent compliance with the conditions of the protocol and follow-up
- •- No pregnant or lactating women
Investigators
Similar Trials
Active, not recruiting
Phase 1
The use of a Topical Anesthetic (EMLA) to assess decreased pain during the Periodontal Probing examChronic PeriodontitisC07.465.714RBR-8h7b5dwniversidade Estadual de Ponta Grossa
Not yet recruiting
Phase 2
Study to assess the impact of insulin on reperfusion injury after skeletal muscle ischaemiaReperfusion injurySLCTR/2014/005Professorial Surgical Unit24
Completed
Not Applicable
A maternal probiotic intervention for infant allergic disease preventioGestational diabetes mellitusACTRN12612000196842Dr Kristin Wickens400
Completed
Phase 3
Evaluation of the effect of intranasal desmopressin spray on complications of kidney biopsyCondition 1: Bleeding. Condition 2: Kidney biopsy.Postprocedural hemorrhage and hematoma of skin and subcutaneous tissue following other procedureL76.22IRCT20201019049075N2Shiraz University of Medical Sciences60
Completed
Phase 3
Evaluation of the effect of intranasal desmopressin spray on the complications of kidney biopsy in renal failureCondition 1: Bleeding. Condition 2: Kidney biopsy. Condition 3: Acute kidney failure.Postprocedural hemorrhage and hematoma of skin and subcutaneous tissue following other procedureAcute kidney failure, unspecifiedL76.22N17.9IRCT20201019049075N1Shiraz University of Medical Sciences60